SC

Sivaram Chandra Chintalapati

Active Director Director DIN 11129313
DIN 11129313 First appointment May 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sivaram Chandra Chintalapati

Data last updated:

Sivaram Chandra Chintalapati is a Director at Axleres Biosciences Private Limited (since 2025). The company operates in Biotechnology.

DIN 11129313
Primary Designation Director
Industry Biotechnology
First Appointment 28 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axleres Biosciences Private Limited U72100KA2025PTC203461
Director28 May 20252025Active

Board colleagues of Sivaram Chandra Chintalapati

NameDINCompanyDesignation
Jegadeesh Thampi10660199Axleres Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Axleres Biosciences Private Limited
Premium access

Shareholding and investment profile for Sivaram Chandra Chintalapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sivaram Chandra Chintalapati

Sivaram Chandra Chintalapati currently holds 1 directorship: Axleres Biosciences Private Limited (Director, since 28 May 2025).

Sivaram Chandra Chintalapati was first appointed on 28 May 2025 as Director at Axleres Biosciences Private Limited.

The current boards of Sivaram Chandra Chintalapati's companies include Jegadeesh Thampi (Axleres Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available